Medicare Reform Ushers in New Rules for Generic Drugs

Time to Read: 1 minutes Practices: Life Sciences Industries: Biotechnology & Pharmaceuticals

Printer-Friendly Version

How new legislation changed the rules governing 180-day exclusivity for generic drug patents, written by Alan Bennett and Joanna Wu for the Washington Legal Foundation.

Printer-Friendly Version

Cookie Settings